Align Technology Previews New Invisalign Products at JPMorgan Healthcare ...( 2008 Product Plan Marks New Directio...),Health
Navigation Links
Align Technology Previews New Invisalign Products at JPMorgan Healthcare Conference
Date:1/8/2008
2008 Product Plan Marks New Direction for Product Development and Delivery
SANTA CLARA, Calif., Jan. 8 /PRNewswire-FirstCall/ -- In conjunction with the annual JPMorgan Healthcare Conference in San Francisco, Align Technology, Inc. (Nasdaq: ALGN) will preview three new Invisalign treatment offerings planned for 2008: a subscription-based orthodontic retention product; a non-adult comprehensive (teen) product; and a turnkey version of Invisalign to help doctors plan and manage cases more efficiently. The new products extend the benefits of the Invisalign system to more patients and will improve the overall treatment process for doctors by adding features that range from streamlined treatment planning and case monitoring support, to specially-engineered aligners and aligner wear indicators, to aligner shipments staged to meet treatment needs.
"For the past two years we have focused on Align's long-term strategy and the opportunity we have to further penetrate our market through product innovation," said Thomas M. Prescott, Align Technology's president and chief executive officer. "This is the year our product development strategy is coming to life. 2008 marks a new direction in the way Align develops and delivers the technology, clinical expertise and benefits of the Invisalign system to our customers and their patients. New products that are designed to increase utilization and overcome barriers to greater adoption are now in pilot, and we are excited about previewing those offerings at the JPMorgan Healthcare Conference today."
Vivera Retainers Deliver a Superior Long-term Retention Product
Vivera retainers are a convenient, long-term retention product designed
for both Invisalign and non-Invisalign patients. Vive
'/>"/>
| SOURCE Align Technology, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Align Technology Executive to Present at Upcoming Financial Conferences
2. WellPoint Announces Realignment of Core Businesses; Names New Executives
3. Align Technology to Announce Third Quarter 2007 Financial Results on October 24, 2007
4. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
5. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
6. Threshold Pharmaceuticals Announces Corporate Realignment
7. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
8. Dallas Among the First to Offer Probiotic Supplement Align(R)
9. McGill researchers link enzyme to breast cancer malignancy
10. Breast Cancer Genes Also Raise Mens Risk for Malignancy
11. iNOS expression may links chronic biliary inflammation to malignant transformation
Post Your Comments:
(Date:11/30/2009)... The launch of Invivo Corporation,s...irst FDA-cleared, fully-automated morphological sy...st of suspicious breast lesions. The ONCAD system ...ciety of North America 2009 Annual Meeting in Chic...xperts in breast MRI, ONCAD for DynaCAD uses a pat...
(Date:11/30/2009)... results in animals , , MONDAY, Nov. 3...uggest that stem cells from transplanted human-der...ng and heart disorders. , Scientists already k...long list of different kinds of cells in the labor...nter in Seoul, Korea, co-author of one of the stud...
(Date:11/30/2009)...wire/ --- Salon Leau announced today they are host...o raise funds and create positive impact in the fi...eds from each haircut and or color will be donated...Salon Leau has been serving the posh Washington DC... widely recognized for her innovation in color, cu...
(Date:11/30/2009)... PHILADELPHIA, Pennsylvania, November 30 /PRNews...From Elsevier,s Top Thought Leaders Provide Insigh... Elsevier, a world leader in healthcare publicati...c health record (EHR) integrated solutions, today,...n Recovery and Reinvestment,Act (ARRA) updates and...
(Date:11/30/2009)...ir response to a "cocaine-cues" video, active coca...ivity in brain regions linked to drug craving, acc...ergy,s Brookhaven National Laboratory. The results...age , suggest that clinical interventions designed...lp cocaine abusers stop using drugs and avoid rela...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3[0] New Breast MRI Technology Enables Enhanced Breast Cancer Detection[0] Cord Blood Stem Cells May Help Treat Heart, Lung Disorders[0] Georgetown Hair Salon Helps St. Jude Find A Cure[0] Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog[0] Brain scan study shows cocaine abusers can control cravings
... Zealand: Though there have been improvements in m...ontract, yet it is considered inadequate, due to w...r general practitioners//. Proposed changes to mat...ociation's GP council, said "They are not seeing t...
... first drug proven to significantly improve the vi...n Friday//.
The drug, Lucentis, is to treat ...where blood vessels behind the retina leak, worsen... to have the wet form of the disease.
Lucent...
...orado: Ken Lay, the founder of Enron, who was admi...oronary, passed away, in the early morning due to ...ed mastermind behind the Enron scandal had succumb...10 counts of fraud and conspiracy on the investors...
...ew Health Canada document available with CanWest N...iation for patients //could "translate in the savi...ncers caused by X-rays kill 780 to 2,500 Canadians...ntly tested and their efficacy and safety remains ...
...wo-year-old boy in Bihar weighs an unbelievable 35...nt doctors to find out the cause. //
Ayush be...id his father Kanhal Singh, who stays in Muzaffarp...hi where doctors said he was a normal child. They ...
... Supreme Court Wednesday criticised the central go...od they were on strike in May protesting quotas//i... be a "model employer".
Conveying its disple...ld act like a model employer. When the doctors wer...
Other Medicine News:Health News:Government Pulled up for Denying Pay to Striking Medicos 2(Date:11/30/2009)... , COVINA, Calif., Nov. 30 Stem...ercialization agreement with Academia Sinica, the ...tary methods and Intellectual Property (IP) relate...ls. This method and IP was pioneered by a team le...ademia Sinica. Professor Lin is currently the exc...
(Date:11/30/2009)..., BLOOMFIELD HILLS, Mich., Nov. 30 /PRNewswire/ ...pping site dedicated exclusively to products appro...s Account (FSA/HSA) claims. The site is also the ...ounter medications, saving shoppers up to 75 perce...urce helps cure two common healthcare headaches - ...
(Date:11/30/2009)... , BOZEN, Italy, November 30 /PRNewswire/ ...veil TPNstation,s development plans and product sp..."Totally Automated Parenteral,Nutrition", a new ke...to be,showcased at Las Vegas, ASHP (Booth # 114). ...m our customers to the,TPNstation,s blueprints and...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3NGA Chair Vermont Governor Douglas to Speak on States Role in Health Care Reform at the National Press Club on September 17 56665 1NGA Chair Vermont Governor Douglas to Speak on States Role in Health Care Reform at the National Press Club on September 17 56665 2Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 1Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 2SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 1SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 2SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 3SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 4[0] StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke[0] eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims[0] Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th
...unces Plans for Advancing AT-1001 into Later Stage...ire/ -- Alba Therapeutics,Corporation today announ...l trial for AT-1001 in subjects with Celiac Diseas...lion people in the United,States. Alba,s study, th...ess dosing requirements for AT-1001 in CD, was des...
...ISVILLE, N.C.--(BUSINESS WIRE)--May 7, 2007 - BioD... announced the results of,a 12 subject, crossover ...th single and multiple BEMA(TM) Fentanyl discs, as...he data demonstrates that,the absolute bioavailabi...very system) of fentanyl from the BEMA(TM) disc wa...
Other Medicine Technology:Alba Therapeutics Corporation Reports Preliminary Phase IIa,Clinical Trial Results for AT-1001 for the Treatment of Celiac,Disease 2Alba Therapeutics Corporation Reports Preliminary Phase IIa,Clinical Trial Results for AT-1001 for the Treatment of Celiac,Disease 3Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In,Absolute Bioavailability Study 2Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In,Absolute Bioavailability Study 3Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In,Absolute Bioavailability Study 4Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In,Absolute Bioavailability Study 5Clearview EASY HCG
SureStep Propoxyphene (PPX)
COC/MAMPII/MOP/THC/AMPII/BAR/BZO300/MTD/TCA
SureStep AMP/COC/MAMP/OPI/THC
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |